Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Linagliptin MeSH Descriptor Data 2025


MeSH Heading
Linagliptin
Tree Number(s)
D03.633.100.759.562
D03.633.100.786.563
Unique ID
D000069476
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069476
Scope Note
A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.
Entry Term(s)
(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-
BI 1356
BI-1356
BI1356
Tradjenta
Trajenta
Pharm Action
Hypoglycemic Agents
Incretins
Dipeptidyl-Peptidase IV Inhibitors
Registry Numbers
3X29ZEJ4R2
0
Related Numbers
668270-12-0
See Also
Sitagliptin Phosphate
Public MeSH Note
2016; LINAGLIPTIN was indexed under PURINES and QUINAZOLINES 2011-2015
History Note
2016 (2011)
Date Established
2016/01/01
Date of Entry
2015/07/06
Revision Date
2016/05/31
Linagliptin Preferred
BI 1356 Narrower
Tradjenta Narrower
page delivered in 0.127s